Fortetropin supplementation prevents the rise in circulating myostatin but not disuse-induced muscle atrophy in young men with limb immobilization: A randomized controlled trial
Fig 5
Plasma myostatin concentration at days 1 and 42 (A) and the percentage change in plasma myostatin concentration from day 1 to day 42 (B). The scatterplots show the correlation between the percentage change in CSA by ultrasonography and myostatin circulation concentration at day 42 (C), and the percentage change in plasma myostatin concentration (D). Boxes represent the 25th to 75th percentile, with the central horizontal lines indicating the median. The whiskers represent the maximal and minimal values, and the cross represents the mean value. FOR-SUPP, Fortetropin® supplement; PLA-SUPP, placebo supplement; CSA, cross-sectional area. * P < 0.05, significantly different from pre within the group, # P < 0.05, significantly different from FOR.